<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/static_war/render/xsl/rss2.xsl" media="screen" type="text/xsl"?>
<rss version="2.0">
  <channel>
    <title>Warwick Evidence &#187; News</title>
    <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/</link>
    <description>The latest from Warwick Evidence &#187; News</description>
    <language>en-GB</language>
    <copyright>(C) 2026 University of Warwick</copyright>
    <lastBuildDate>Thu, 31 Mar 2022 16:05:42 GMT</lastBuildDate>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <generator>SiteBuilder2, University of Warwick, http://go.warwick.ac.uk/sitebuilder</generator>
    <category>Aileen Clarke</category>
    <category>Asprinin</category>
    <category>University of Warwick</category>
    <category>Warwick Evidence</category>
    <category>Warwick Medical School</category>
    <category>Untagged</category>
    <item>
      <title>New Publication</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f20</link>
      <description>&lt;p&gt;Couper K, Taylor-Phillips S, Grove A, Freeman K, Osokogu O, Court R, Mehrabian A, Morley P, Nolan JP, Soar J, Perkins GD. (2020) COVID-19 in cardiac arrest and infection risk to rescuers: a systematic review. Resuscitation. &lt;a href="https://doi.org/10.1016/j.resuscitation.2020.04.022"&gt;https://doi.org/10.1016/j.resuscitation.2020.04.022&lt;/a&gt;&lt;/p&gt;</description>
      <category>Warwick Evidence</category>
      <pubDate>Fri, 24 Apr 2020 11:23:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f20</guid>
    </item>
    <item>
      <title>New Publication</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1f</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Fraser, H., Geppert, J., Johnson, R., Johnson, S., Connock, M., Clarke, A., Taylor-Phillips, S. &amp;amp; Stinton, C. (2019) Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review. &lt;i&gt;Orphanet Journal of Rare Diseases&lt;/i&gt;, 14 (1): 258.&lt;/p&gt;
&lt;p class="EndNoteBibliography"&gt;For the full article see &lt;a href="https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1226-y#citeas"&gt;here&lt;/a&gt;.&lt;/p&gt;</description>
      <category>Warwick Evidence</category>
      <pubDate>Tue, 26 Nov 2019 14:30:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1f</guid>
    </item>
    <item>
      <title>New Publication</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1e</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Auguste, P., Madan, J., Tsertsvadze, A., Court, R., McCarthy, N., Sutcliffe, P., Taylor-Phillips, S., Pink, J. &amp;amp; Clarke, A. (2019) Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy. &lt;i&gt;Int J Tuberc Lung Dis&lt;/i&gt;, 23 (11): 1178-1190.&lt;/p&gt;
&lt;p class="EndNoteBibliography"&gt;For the full paper see &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/31718754"&gt;here&lt;/a&gt;.&lt;/p&gt;</description>
      <category>Warwick Evidence</category>
      <pubDate>Tue, 26 Nov 2019 14:24:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1e</guid>
    </item>
    <item>
      <title>New Publication for Warwick Evidence</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1d</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Armoiry, X., Spath, H.-M., Clarke, A., Connock, M., Sutcliffe, P. &amp;amp; Dussart, C. (2019) Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma. &lt;i&gt;Journal of Market Access &amp;amp; Health Policy&lt;/i&gt;, 7 (1): 1648971.&lt;/p&gt;

&lt;p class="EndNoteBibliography"&gt;For the full paper see &lt;a href="https://www.tandfonline.com/doi/full/10.1080/20016689.2019.1648971"&gt;here&lt;/a&gt;.&lt;/p&gt;</description>
      <category>Aileen Clarke</category>
      <category>University of Warwick</category>
      <category>Warwick Evidence</category>
      <category>Warwick Medical School</category>
      <pubDate>Mon, 12 Aug 2019 10:15:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1d</guid>
    </item>
    <item>
      <title>New Publication for Warwick Evidence</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1c</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Connock, M., Armoiry, X., Tsertsvadze, A., Melendez-Torres, G. J., Royle, P., Andronis, L. &amp;amp; Clarke, A. J. B. C. (2019) Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials. 19 (1): 392.&lt;/p&gt;

&lt;p class="EndNoteBibliography"&gt;&lt;/p&gt;

&lt;p class="EndNoteBibliography"&gt;For the full paper see &lt;a href="https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5507-6"&gt;here&lt;/a&gt;.&lt;/p&gt;</description>
      <pubDate>Mon, 03 Jun 2019 14:24:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1c</guid>
    </item>
    <item>
      <title>New publication for Warwick Evidence</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1b</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Taylor-Phillips, S. &amp;amp; Stinton, C. (2019) Fatigue in radiology: a fertile area for future research. &lt;i&gt;Br J Radiol&lt;/i&gt;, 20190043.&lt;/p&gt;

&lt;p class="EndNoteBibliography"&gt;&lt;/p&gt;

&lt;p class="EndNoteBibliography"&gt;For the full paper see &lt;a href="https://www.ncbi.nlm.nih.gov/pubmed/30933540"&gt;here&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 03 Jun 2019 14:22:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1b</guid>
    </item>
    <item>
      <title>New Clinical Trial</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d840f1a</link>
      <description>&lt;p&gt;Dr Hema Mistry is working on a new clinical trial that aims to find the best way to feed premature babies:&lt;/p&gt;

&lt;p&gt;&lt;a href="https://warwick.ac.uk/newsandevents/pressreleases/new_clinical_trial"&gt;https://warwick.ac.uk/newsandevents/pressreleases/new_clinical_trial&lt;/a&gt;&amp;nbsp;&lt;/p&gt;</description>
      <pubDate>Thu, 21 Mar 2019 07:15:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d840f1a</guid>
    </item>
    <item>
      <title>Admin to Research - Hannah Fraser's success story</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d830f19</link>
      <description>&lt;p&gt;Hannah Fraser joined Warwick Evidence on the 1st September 2018. The team is more than proud to have her on board - Hannah completed her MSc in Health Research with distinction. Before Hannah joined Warwick Evidence, she worked as Research Project Administrator for CLAHRC Theme 3. &lt;a href="https://warwick.ac.uk/fac/sci/med/study/cpd/research/rmhs/hfraser/"&gt;Here is her success story.&lt;/a&gt;&amp;nbsp;&lt;/p&gt;</description>
      <pubDate>Mon, 04 Mar 2019 07:39:21 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d830f19</guid>
    </item>
    <item>
      <title>Where next for dry AMD and Stargardt research?</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d830f18</link>
      <description>&lt;p&gt;A team from Warwick Medical School reviewed hundreds of articles about possible treatments to identify emerging treatments for the dry form of age-related macular degeneration (AMD), and for Stargardt disease. See &lt;a href="https://www.macularsociety.org/news/where-next-dry-amd-and-stargardt-research?dm_i=37VE,TCYN,3032NQ,313E9,1"&gt;here&lt;/a&gt; for the full artcile.&lt;/p&gt;</description>
      <category>Warwick Medical School</category>
      <pubDate>Mon, 14 Jan 2019 09:58:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d830f18</guid>
    </item>
    <item>
      <title>New HTA Publication</title>
      <link>https://warwick.ac.uk/fac/sci/med/about/centres/warwickevidence/newspage/?newsItem=8a1785d77e9c0080017ebff90d830f17</link>
      <description>&lt;p class="EndNoteBibliography"&gt;Waugh, N. L., Emma; Colquitt, Jill; Royle, Pamela; Yeong, Jian Lee; Hoad, Geraldine; Lois, Noemi (2018) Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review. . &lt;i&gt;Health Technology Assessment&lt;/i&gt;, 22 (27)&lt;/p&gt;</description>
      <category>Warwick Evidence</category>
      <category>Warwick Medical School</category>
      <pubDate>Mon, 11 Jun 2018 10:11:00 GMT</pubDate>
      <guid isPermaLink="false">8a1785d77e9c0080017ebff90d830f17</guid>
    </item>
  </channel>
</rss>
